After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working.

The language network in your brain can be seen, even if you aren't saying a word. For a study published in Nature Communications, researchers used data from more than 1,900 functional magnetic ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

Vanillin, a common flavoring chemical in e-cigarettes, may disrupt the normal development of embryos in pregnant women who vape, according to a study published today (Thursday) in Human Reproduction, ...

Obesity is a global health concern that can contribute to diabetes, cardiovascular disease, and other metabolic disorders. Though there are many health conditions that can lead to it, an increasingly ...

Bacteria shed membrane-enclosed tiny particles filled with proteins, lipids, DNA, RNA and metabolites. These particles, commonly known as bacterial extracellular vesicles (BEVs), are now being ...

Announcing a new article publication for Zoonoses journal. Serological evidence of spotted fever group rickettsioses (SFGRs) ...

NPs continue to yield first-in-class and best-in-class therapeutics, driving innovation across anti-infectives, oncology, and various other disease areas. A recent audit of global approvals from 2014 ...

Coffee is one of the world's most widely consumed beverages, and previous research has linked its consumption to a lower risk of conditions such as type 2 diabetes and cardiovascular disease. However, ...

Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering ...

Researchers created an open-access dataset comparing two wrist-worn heart rate monitors with a chest-strap reference during ...

Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with millions-or even billions-of antibody candidates, but only a tiny fraction ...